The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

Researchers have discovered in a new study that women diagnosed with gestational diabetes mellitus (GDM) earlier than 24 ...

HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes Mellitus HONG KONG - April 15, 2025 (NEWMEDIAWIRE) - HighTide ...

C-peptide's dual role involves protective mechanisms against DR and potential harmful effects in type 2 diabetes. Monitoring FCP levels is crucial for managing DR risk in patients with type 2 diabetes ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA ...

There are no approved treatments for nonrelapsing secondary progressive multiple sclerosis. In a phase 3, double-blind, placebo-controlled, event-driven trial, we randomly assigned participants ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Background Musculoskeletal symptoms limit adherence to exercise interventions for individuals with type 2 diabetes. People with diabetes may be susceptible to tendinopathy due to chronically elevated ...

Type 2 diabetes mellitus (T2DM) occurs when the body cannot use insulin properly, causing sugar to build up in the blood. T2DM is the type of diabetes you can acquire due to risk factors like obesity ...

Secondary hyperhidrosis can result from: Diabetes can cause neuropathy, or nerve damage, when blood sugar levels or blood triglycerides are too high. This can happen if diabetes is not treated or ...